Get the Stockscreener App
10.18
3.46%
0.34
Pre-market:
10.26
0.08
+0.79%
Immatics N V stock is traded at $10.18, with a volume of 398.30K.
It is up +3.46% in the last 24 hours and up +8.99% over the past month.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
See More
Previous Close:
$9.84
Open:
$9.95
24h Volume:
398.30K
Relative Volume:
0.92
Market Cap:
$1.36B
Revenue:
$58.49M
Net Income/Loss:
$-105.04M
P/E Ratio:
-7.8326
EPS:
-1.2997
Net Cash Flow:
$-13.78M
1W Performance:
-1.07%
1M Performance:
+8.99%
6M Performance:
+77.97%
1Y Performance:
+134.56%
1-Day Range:
$9.56
$10.31
1-Week Range:
$9.39
$10.46
52-Week Range:
$3.30
$12.41
Immatics N V Stock (IMTX) Company Profile
Compare IMTX vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IMTX
Immatics N V
|
10.18 | 1.32B | 58.49M | -105.04M | -13.78M | -1.2997 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.89 | 120.48B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.50 | 81.05B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
749.56 | 46.33B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.30 | 42.26B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
299.02 | 32.87B | 5.36B | 287.73M | 924.18M | 2.5229 |
Immatics N V Stock (IMTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-18-25 | Initiated | Guggenheim | Buy |
| May-28-25 | Initiated | Deutsche Bank | Buy |
| Oct-07-24 | Initiated | Piper Sandler | Overweight |
| Nov-02-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-31-23 | Initiated | Mizuho | Buy |
| Mar-24-23 | Initiated | Bryan Garnier | Buy |
| Nov-20-20 | Initiated | BofA Securities | Buy |
| Sep-22-20 | Initiated | Goldman | Buy |
| Jul-27-20 | Initiated | SVB Leerink | Outperform |
| Jul-24-20 | Initiated | Jefferies | Buy |
View All
Immatics N V Stock (IMTX) Latest News
immatics biotechnologies GmbH (IMTXW) Competitors - Meyka
(IMTX) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Immatics (NASDAQ:IMTX) Lowered to “Sell” Rating by Wall Street Zen - Defense World
IMTX SEC FilingsImmatics N.V 10-K, 10-Q, 8-K Forms - Stock Titan
Immatics N.V. (NASDAQ:IMTX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Immatics N.V. (IMTX) Stock Analysis: Potential 91% Upside Amid Strong Buy Ratings - DirectorsTalk Interviews
Trade Report: Is PACK a defensive stockWeekly Trading Summary & Advanced Technical Signal Analysis - baoquankhu1.vn
Energy Moves: Is Immatics NV in a long term uptrendPortfolio Risk Summary & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
Immatics (NASDAQ:IMTX) Trading Down 5% – Here’s What Happened - Defense World
IMTX PE Ratio & Valuation, Is IMTX Overvalued - Intellectia AI
Is Immatics N.V. a defensive stockQuarterly Trade Report & High Accuracy Swing Entry Alerts - mfd.ru
Aug Gainers: Whats next for Immatics NV Equity Warrant stockTrade Analysis Report & AI Driven Stock Price Forecasts - baoquankhu1.vn
Wall Street Zen Upgrades Immatics (NASDAQ:IMTX) to Hold - MarketBeat
Immatics N.V. (IMTX): Investor Outlook Reveals an 85% Upside Potential Amidst Groundbreaking Cancer Therapies - DirectorsTalk Interviews
RTW INVESTMENTS, LP Increases Stake in Immatics NV - GuruFocus
Can Immatics N.V. Equity Warrant expand into new marketsEarnings Recap Report & Smart Swing Trading Techniques - mfd.ru
Can Immatics N.V. Equity Warrant reach resistance levels soonJuly 2025 Chart Watch & Risk Controlled Stock Pick Alerts - mfd.ru
Will Immatics N.V. (4A3) stock gain from green policiesBuy Signal & Reliable Momentum Entry Alerts - mfd.ru
Immatics (NASDAQ:IMTX) Shares Down 5%Time to Sell? - MarketBeat
Liquidity Mapping Around (IMTX) Price Events - Stock Traders Daily
Exit Recap: Is Immatics NV a cyclical or defensive stockPortfolio Gains Report & Real-Time Market Trend Scan - baoquankhu1.vn
RTW Investments reveals 8.5% Immatics N.V. (IMTX) stake in Schedule 13G/A - Stock Titan
Institution Moves: Is Flushing Financial Corporation attractive at current valuationQuarterly Performance Summary & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
What Immatics (IMTX)'s Melanoma Orphan Drug Designation Means For Shareholders - Sahm
Immatics N.V. (IMTX) Stock Analysis: Near 93% Upside Potential Drives Investor Interest - DirectorsTalk Interviews
Does Immatics N.V. stock have upside surprise potentialQuarterly Earnings Report & Daily Technical Forecast Reports - mfd.ru
Can Immatics N.V. Equity Warrant be the next market leader2025 Key Highlights & Consistent Income Trade Ideas - mfd.ru
Immatics (IMTX) Receives FDA Orphan Status for Melanoma Treatmen - GuruFocus
Immatics (NASDAQ:IMTX) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Whale Trades: Will Immatics NV Equity Warrant benefit from government policyJuly 2025 News Drivers & Low Risk Entry Point Guides - baoquankhu1.vn
Pharma News: What is the target price for Immatics NV stockMarket Performance Summary & Expert Verified Movement Alerts - baoquankhu1.vn
Why (IMTX) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Inflation Data: Is Immatics NV a cyclical or defensive stockQuarterly Trade Summary & Weekly High Return Forecasts - baoquankhu1.vn
Weekly Recap: Will Immatics NV Equity Warrant outperform its industry peersPortfolio Risk Report & Consistent Profit Alerts - baoquankhu1.vn
Is Immatics N.V. Equity Warrant stock undervalued vs historical averages2025 Key Lessons & Risk Controlled Swing Alerts - mfd.ru
Loss Report: Will Immatics N.V. Equity Warrant benefit from current market trends2025 Pullback Review & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Immatics N.V. (NASDAQ:IMTX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Volume Report: Should I set a stop loss on Immatics NVWeekly Investment Report & Expert Verified Movement Alerts - baoquankhu1.vn
Is Immatics N.V. Equity Warrant stock trending bullish2025 Price Momentum & Growth Oriented Trading Recommendations - mfd.ru
Immatics N.V. (IMTX) Stock Analysis: Exploring the 103.89% Potential Upside in the Biotechnology Sector - DirectorsTalk Interviews
Can Immatics N.V. Equity Warrant generate free cash flowInsider Selling & Risk Controlled Stock Alerts - mfd.ru
Understanding Momentum Shifts in (IMTX) - Stock Traders Daily
What’s the outlook for Immatics N.V.’s sectorInsider Selling & Long-Term Growth Plans - mfd.ru
Should you buy the dip on Immatics N.V.July 2025 Chart Watch & Fast Gaining Stock Reports - mfd.ru
Highs Report: Can IF Bancorp Inc continue delivering strong returnsEarnings Recap Summary & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Aug Update: Will Immatics NV Equity Warrant benefit from government policyMarket Growth Report & Consistent Profit Trade Alerts - baoquankhu1.vn
Immatics N.V. (IMTX) Investor Outlook: Exploring An 88% Upside Potential In Biotech - DirectorsTalk Interviews
Downgrade Watch: Will Immatics NV Equity Warrant benefit from current market trends2025 Price Momentum & Weekly Momentum Stock Picks - baoquankhu1.vn
Portfolio Recap: Can LGVN deliver alphaWeekly Trade Analysis & Smart Investment Allocation Insights - baoquankhu1.vn
ImmunityBio Holds Meeting with FDA on Anktiva Application - Intellectia AI
Aug Drivers: Is Immatics NV forming a breakout patternWall Street Watch & Community Shared Stock Ideas - baoquankhu1.vn
Immatics N V Stock (IMTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
6.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):